BFM
LAB icon

Boothbay Fund Management’s Standard BioTools LAB Stock Holding History

Boothbay Fund Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2K Sell
70,760
-1,848
-3% -$1.75K ﹤0.01% 2087
2026
Q1 		$66.7K Buy
+72,608
New +$87.9K ﹤0.01% 1904
2025
Q4 		– Sell
-36,714
Closed -$47.7K – 2173
2025
Q3 		$47.7K Buy
+36,714
New +$48.1K ﹤0.01% 1789
2024
Q3 		– Sell
-73,190
Closed -$130K – 1783
2024
Q2 		$130K Sell
73,190
-258,472
-78% -$632K ﹤0.01% 1331
2024
Q1 		$899K Sell
331,662
-476,196
-59% -$1.15M 0.02% 790
2023
Q4 		$1.79M Sell
807,858
-398,156
-33% -$850K 0.05% 534
2023
Q3 		$3.5M Sell
1,206,014
-1,096,264
-48% -$2.87M 0.08% 321
2023
Q2 		$4.44M Hold
2,302,278
– – 0.1% 253
2023
Q1 		$4.49M Hold
2,302,278
– – 0.09% 289
2022
Q4 		$2.69M Hold
2,302,278
– – 0.06% 473
2022
Q3 		$2.53M Sell
2,302,278
-18,844
-0.8% -$28.5K 0.06% 452
2022
Q2 		$3.71M Buy
2,321,122
+18,844
+0.8% +$46.6K 0.1% 294
2022
Q1 		$8.27M Hold
2,302,278
– – 0.19% 100
2021
Q4 		$9.03M Hold
2,302,278
– – 0.21% 95
2021
Q3 		$15.2M Hold
2,302,278
– – 0.42% 32
2021
Q2 		$14.2M Buy
2,302,278
+1,837,258
+395% +$9.82M 0.46% 25
2021
Q1 		$2.1M Buy
+465,020
New +$2.55M 0.08% 304

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Boothbay Fund Management's LAB Position: Q2 2026 in Review

Boothbay Fund Management reduced its Standard BioTools (LAB) stake by 2.5% in Q2 2026, selling an estimated $1.75K and leaving 70,760 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

Boothbay Fund Management first reported a position in LAB in Q1 2021 and has held it in 17 quarters since. The position peaked at $15.2M in Q3 2021. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Boothbay Fund Management held 70,760 shares of Standard BioTools worth $58.2K as of Q2 2026.
  • Boothbay Fund Management sold 1,848 Standard BioTools shares in Q2 2026, an estimated $1.75K.
  • Standard BioTools made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2087 holding.
  • Boothbay Fund Management first reported a position in Standard BioTools in Q1 2021 and has held it in 17 quarters since.
  • Boothbay Fund Management's Standard BioTools position peaked at $15.2M in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.